Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701

OBJECTIVE: The aim of this multicenter study was to determine the appropriate administration schedule for S-1, an oral fluoropyrimidine, for adjuvant chemotherapy in patients with completely resected pathological-Stage IA (tumor diameter, 2–3 cm) non–small-cell lung cancer. METHODS: Patients were ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Soh, Junichi, Okumura, Norihito, Nakata, Masao, Nakamura, Hiroshige, Fukuda, Minoru, Kataoka, Masafumi, Kajiwara, Shinsuke, Sano, Yoshifumi, Aoe, Motoi, Kataoka, Kazuhiko, Hotta, Katsuyuki, Matsuo, Keitaro, Toyooka, Shinichi, Date, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025397/
https://www.ncbi.nlm.nih.gov/pubmed/27207886
http://dx.doi.org/10.1093/jjco/hyw062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025397/
https://www.ncbi.nlm.nih.gov/pubmed/27207886
http://dx.doi.org/10.1093/jjco/hyw062

Ejemplares similares